NYSEARCA:XBI - SPDR S&P Biotech Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$100.71 +1.86 (+1.88 %)
(As of 06/20/2018 01:15 PM ET)
Previous Close$98.85
Today's Range$99.35 - $100.76
52-Week Range$74.09 - $99.08
Volume335,313 shs
Average Volume4.82 million shs
Market Capitalization$5.12 billion
P/E RatioN/A
Dividend Yield0.19%
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

Receive XBI News and Ratings via Email

Sign-up to receive the latest news and ratings for XBI and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer SSgA
Fund NameSPDR S&P Biotech ETF
Tax ClassificationRegulated Investment Company
Inception Date1/31/2006
Fund ManagerMichael Feehily, Karl Schneider, Raymond Donofrio

Fund Focus

Asset ClassEquity
BenchmarkS&P Biotechnology Select Industry TR USD
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$4.95 billion
Average Daily Volume$5.48 million

ETF Expenses

Management Fee0.35%
Other Expenses0.00%
Total Expenses0.35%
Fee Waiver0.00%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorSSGA Funds Management, Inc.
AdvisorSSgA Funds Management, Inc.
CustodianState Street Bank and Trust Company
DistributorState Street Global Advisors Funds Distributors, LLC
Transfer AgentState Street Bank and Trust Company
Lead Market MakerVirtu Financial

Geographic Exposure of SPDR S&P Biotech (NYSEARCA:XBI)
Currency Exposure of SPDR S&P Biotech (NYSEARCA:XBI)
Sector Exposure of SPDR S&P Biotech (NYSEARCA:XBI)
Industry Exposure of SPDR S&P Biotech (NYSEARCA:XBI)

SPDR S&P Biotech (NYSEARCA:XBI) Frequently Asked Questions

What is SPDR S&P Biotech's stock symbol?

SPDR S&P Biotech trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."

How often does SPDR S&P Biotech pay dividends? What is the dividend yield for SPDR S&P Biotech?

SPDR S&P Biotech announced a quarterly dividend on Monday, June 18th. Stockholders of record on Monday, June 18th will be given a dividend of $0.0585 per share on Wednesday, June 20th. This represents a $0.23 dividend on an annualized basis and a dividend yield of 0.23%. The ex-dividend date of this dividend is Friday, June 15th. View SPDR S&P Biotech's Dividend History.

Who are SPDR S&P Biotech's key executives?

SPDR S&P Biotech's management team includes the folowing people:
  • James E. Ross, President, Trustee (Age 52)
  • Peter A. Ambrosini, Chief Compliance Officer (Age 69)
  • Michael P. Riley, Vice President (Age 44)
  • Gary L. French, Treasurer (Age 64)
  • John W. Clark, Assistant Treasurer (Age 46)
  • Matthew W. Flaherty, Assistant Treasurer (Age 42)
  • Chad C. Hallett, Assistant Treasurer of Street tracks series trust (Age 47)
  • Mary Moran Zeven, Secretary (Age 52)
  • Scott M. Zoltowski, Assistant Secretary (Age 44)
  • Dave Kelly, Independent Trustee

Has SPDR S&P Biotech been receiving favorable news coverage?

Press coverage about XBI stock has trended somewhat positive on Wednesday, Accern Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. SPDR S&P Biotech earned a news sentiment score of 0.09 on Accern's scale. They also gave media stories about the exchange traded fund an impact score of 46.13 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

Who are SPDR S&P Biotech's major shareholders?

SPDR S&P Biotech's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include JPMorgan Chase & Co. (2.74%), Clal Insurance Enterprises Holdings Ltd (2.39%), CI Investments Inc. (1.10%), First Republic Investment Management Inc. (0.82%), SG Americas Securities LLC (0.69%) and LPL Financial LLC (0.48%). View Institutional Ownership Trends for SPDR S&P Biotech.

Which institutional investors are selling SPDR S&P Biotech stock?

XBI stock was sold by a variety of institutional investors in the last quarter, including QVR LLC, Thrivent Financial for Lutherans, Envestnet Asset Management Inc., Opus Point Partners Management LLC, Beaumont Financial Partners LLC, Cavalier Investments LLC, BB&T Securities LLC and Cornerstone Advisory LLP. View Insider Buying and Selling for SPDR S&P Biotech.

Which institutional investors are buying SPDR S&P Biotech stock?

XBI stock was bought by a variety of institutional investors in the last quarter, including Clal Insurance Enterprises Holdings Ltd, CI Investments Inc., JPMorgan Chase & Co., Whittier Trust Co., Barometer Capital Management Inc., Q3 Asset Management, State of Tennessee Treasury Department and Smart Portfolios LLC. View Insider Buying and Selling for SPDR S&P Biotech.

How do I buy shares of SPDR S&P Biotech?

Shares of XBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is SPDR S&P Biotech's stock price today?

One share of XBI stock can currently be purchased for approximately $100.49.

How big of a company is SPDR S&P Biotech?

SPDR S&P Biotech has a market capitalization of $5.12 billion.

How can I contact SPDR S&P Biotech?

SPDR S&P Biotech's mailing address is One Lincoln Street, Boston, 02111, United States. The exchange traded fund can be reached via phone at +1-866-7872257.

MarketBeat Community Rating for SPDR S&P Biotech (XBI)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  49 (Vote Outperform)
Underperform Votes:  57 (Vote Underperform)
Total Votes:  106
MarketBeat's community ratings are surveys of what our community members think about SPDR S&P Biotech and other stocks. Vote "Outperform" if you believe XBI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XBI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.